期刊文献+

肝移植围手术期中的人工肝支持 被引量:2

Artificial liver support system used in the perioperative period of liver transplantation
下载PDF
导出
摘要 人工肝脏支持系统是以血液净化为基础的体外循环系统,包括血液透析、血液滤过、血液灌流、血浆置换等方法。临床应用非生物型人工肝脏尤其是血浆置换技术,能有效地解决高胆红素血症、内毒素血症、毒性物质积蓄与氨基酸代谢障碍及水、电解质、酸碱失衡等问题,改善患者内环境,促进肝细胞再生,纠正肝性脑病、降低重型肝炎的病死率,使患者能渡过危险的肝功能衰竭难关而获得生存。通过人工肝治疗,不仅可明显改善肝衰竭患者的全身情况,为手术降低风险,为寻找供肝争得保贵的时间,而且能有效地改善肝移植术后早期患者的生理紊乱状况,帮助渡过排斥反应期,有利于移植肝功能的恢复。因此,人工肝可成为肝移植的桥梁。文章从人工肝脏支持系统的功能出发,分析其特点,探讨其应用于人体原位肝移植围手术期的方法及其发展方向。 An artificial liver support system (ALSS) is a body circulatory system aims to blood purification, which consists of plasma exchange, hemodialysis, hemoperfusion, in combination with hemodiafiltration. The clinical application of non-biological artificial liver, especially plasma exchange technology, can solve the problem such as hyperbilirubinemia, endotoxemia, toxic substance accumulation and disorder of amino acid metabolism, which would save patients' lives. ALSS can significantly improve the general physical condition, reduce operative risk, as well as relieve physiologic derangement after liver transplantation. Therefore, artificial liver serves as a bridge for liver transplantation. This paper analyzes the characteristics of ALSS, explores the methods of ALSS application in perioperative period of liver transplantation, and discusses its developing orientation.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第31期6125-6128,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献22

  • 1刘剑峰,李明,杨巍,楼晗芬,宋涛.新型生物人工肝支持系统的控制与实现[J].生物医学工程学杂志,2008,25(2):445-449. 被引量:3
  • 2刘剑峰,李明,杨巍,楼晗芬.一种新型生物人工肝支持系统[J].透析与人工器官,2007,18(1):9-13. 被引量:5
  • 3李骥,卢明芹,陈永平,廖毅,虞冠峰,赵晓燕,马旭阳.人工肝脏支持系统在肝脏移植围手术期的应用[J].透析与人工器官,2006,17(4):15-18. 被引量:3
  • 4楼晗芬,李明,周晓峰,刘剑峰.生物型人工肝支持系统新型曝气装置的研究[J].现代科学仪器,2006,23(4):50-52. 被引量:2
  • 5朱宇佳.人工肝支持系统的临床应用研究进展[J].医学综述,2006,12(9):551-553. 被引量:1
  • 6Matsumura KN,Guevara GR,Huston H,et al.Hybrid bioartificial liver in hepatic failure:preliminary clinical report.Surgery.1987;101(1):99-103.
  • 7Koball S,Peszynki P,Freytag J,et al.Removal of albu2 min bound toxins with the MARS2system shows protective effects on hepatocytes1 ASAIOL.2000 ;46:2391.
  • 8Stange J,Mitzner S,Klammt S.Inhibition of NO synthase by arginine removal by liver support(MARS)seems to be only a cofactor for reversal of hypotension in decompensated liver cirrhosis that seems to be linked more to removal of protein bound toxins.HEPATOLOGY.2000; 32:1812.
  • 9Awad SS,Sawada S,Soldes OS,et al.Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system? ASAIO J.1999;45(1):47-49.
  • 10Majcher-Peszynska,J,Hehl EM,Wacke R,et al.Removal of Diazepam as a marker molecule for Benzodiazepine-like substances(BLS)during albumin dialysis.Clin Pharmacology.1999:55:A26.

二级参考文献53

  • 1郑树森,徐骁,李兰娟,梁廷波,高峰,王伟林,沈岩,杨芊.人工肝支持系统联合肝移植治疗晚期重型肝炎的临床经验[J].中华普通外科杂志,2004,19(9):520-522. 被引量:9
  • 2张六六,许春燕,牛津立,沈志松.中空纤维膜无泡供氧过程的传质性能研究[J].膜科学与技术,2004,24(5):16-21. 被引量:16
  • 3王文奇.生物型人工肝的研究进展[J].山东医药,2005,45(31):66-67. 被引量:1
  • 4刘剑峰,李明,杨巍,项红升.APC技术在生物型人工肝支持系统中的应用[J].计算机测量与控制,2005,13(10):1048-1051. 被引量:2
  • 5Stange, J, Mitzner S, Klammt S, et la. Inhibition of NO synthase by arginine removal by liver support (MARS)seems to be only a cofactor for reversal of hypotension in decompensated liver cirrhosis that seems to be linked more to removal of protein bound t
  • 6Joly A, Desjardins JF, Fremond B, et al. Survivial, proliferation and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a rellable bioartificial liver. Transplantation, 1997, 63 (6) :795-803.
  • 7Mullen KD. Treatment of hepatorenal syndrome: lessons from the MARS trial. Hepatology, 2002, 35: 492-493.
  • 8Mitzner SR, Stange J. Treatment of hepatorenal syndrome:lessons from the MARS trials. Hepatology, 2002,35 (2):492-293.
  • 9Sorkine P, Abraham RB, Szold O. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure.Crit Care Med, 2001, 29 (7) : 1332-1336.
  • 10Koball S, Peszynki P, Freytag J, et al. Removal of albumin bound toxins with the MARS-system shows protective effects on hepatocytes. ASAIOL, 2000, 46: 239.

共引文献19

同被引文献27

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部